v3.25.1
Business (Tables)
9 Months Ended
Mar. 31, 2025
Schedule Of Entities In Control [Abstract]  
Summary of entities in control
The consolidated financial statements of Benitec Biopharma Inc. are presented in United States dollars and consist of Benitec Biopharma Inc. and its wholly owned subsidiaries as listed below. Aside from Benitec Biopharma Proprietary Limited, the international subsidiaries are dormant.
 
    
Principal place of
business/country of
incorporation
Benitec Biopharma Proprietary Limited (“BBL”)   
Australia
Benitec Australia Proprietary Limited   
Australia
Benitec Limited   
United Kingdom
Benitec, Inc.   
USA
Benitec LLC   
USA
RNAi Therapeutics, Inc.   
USA
Tacere Therapeutics, Inc.   
USA
Benitec IP Holdings, Inc.   
USA